<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> is a highly complex breakdown of <z:mpath ids='MPATH_458'>normal</z:mpath> <z:mp ids='MP_0001532'>physiology</z:mp> characterized by <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo>, and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is a major manifestation of this syndrome, although increased risk for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) often precedes the <z:hpo ids='HP_0003674'>onset</z:hpo> of frank clinical <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Prevention and cure for this disease constellation is of major importance to world health </plain></SENT>
<SENT sid="3" pm="."><plain>Because the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> affects multiple interacting organ systems (i.e., it is a <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e>), a systems-level analysis of disease evolution is essential for both complete elucidation of its pathophysiology and improved approaches to therapy </plain></SENT>
<SENT sid="4" pm="."><plain>The goal of this review is to provide a perspective on systems-level approaches to <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, with particular emphasis on type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>We consider that <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndromes</z:e> take over inherent dynamics of our body that ensure robustness against unstable food supply and pathogenic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, and lead to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> that ultimately results in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>This exemplifies how trade-offs between robustness against common perturbations (unstable food and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>) and fragility against unusual perturbations (high-energy content foods and low-energy utilization lifestyle) is exploited to form <z:hpo ids='HP_0011010'>chronic</z:hpo> diseases </plain></SENT>
<SENT sid="7" pm="."><plain>Possible therapeutic approaches that target fragility of emergent robustness of the disease state have been discussed </plain></SENT>
<SENT sid="8" pm="."><plain>A detailed molecular interaction map for adipocyte, hepatocyte, skeletal muscle cell, and pancreatic beta-cell cross-talk in the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> can be viewed at http://www.systems-biology.org/001/003.html </plain></SENT>
</text></document>